Results 1 to 10 of about 60,658 (250)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Diabetes, 2009
Antonello Pessi, Alessandro Pocai, Elisabetta Bianchi   +2 more
exaly  

Lateral Allosterism in the Glucagon Receptor Family: Glucagon-Like Peptide 1 Induces G-Protein-Coupled Receptor Heteromer Formation

Molecular Pharmacology, 2012
Vincent Mutel
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

New England Journal of Medicine
openaire   +2 more sources

Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes

American Journal of Obstetrics and Gynecology
Marisa Imbroane
exaly  

Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy

Frontiers in Endocrinology
Wu Tianqiang, Ren Na
exaly  

The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats

EBioMedicine
Kirsten Raun, Wouter Hogendorf
exaly  

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study

Thyroid
exaly  

Glucagon-Like Peptide 1 Receptor Agonist

openaire   +1 more source

COAGONISTS OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AND NEUROPEPTIDE Y2 RECEPTOR

2017
DOYLE ROBERT, BONACCORSO RON
openaire   +2 more sources